Notice of Intent to Sole Source Tissue Sealant.docx
DOCX document 17 KB Posted
- Attached to
- Notice of Intent to Sole Source, Tissue Sealant
- Solicitation number
- HT9425-24-NOI-EMZ04
- Issued by
-
Defense Health Agency
About this file
This document is a Notice of Intent to Sole Source for a research and development requirement to evaluate the wound healing, antimicrobial, and hemostatic properties of a new tissue sealant on an open wounded animal model. The government intends to award a sole source contract to Bridge PTS, Incorporated, as the only source capable of providing the requested research and development services. The objectives are to determine the safety and efficacy of the new tissue sealants in promoting wound healing and hemostasis, and to evaluate their antimicrobial properties on an open wound in a live model. The NAICS code is 541380 - Testing Laboratory Services and Veterinary, Natural and Life Sciences, with a $19 million small business size standard. Responses articulating the ability to provide the required services must be submitted within 15 days of this notice. If no responses are received, the contract will be awarded without further competition.
View the file
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Notice of Intent to Sole Source
The United States Army Medical Research Acquisition Activity (USAMRAA), on behalf of the United States Air Force (USAF) 59th Medical Wing, Science and Technology Office is issuing this notice of intent to award a new contract on a sole source basis. This is not a request for proposals. This notice does not represent a commitment by the Government to pay for costs incurred from the preparation and/or submission of data in response to this notice.
The Government intends to award a sole source contract to the Bridge PTS, Incorporated for the Advancement of Military Medicine for a research and development requirement. This research study is titled ‘Evaluation of the wound healing, antimicrobial and hemostatic properties of a new tissue sealant on an open wounded animal model.’
The main objectives are summarized as follows:
· Determine the safety/efficacy of new tissue sealants as products capable of promoting wound healing and hemostatic properties through skin re-attachment in comparison to traditional wound repair methods.
· Evaluate the antimicrobial and hemostatic properties of the tissue sealants on an open wound in a live model.
This contract will be issued on a sole source basis as the Government’s market research indicates that the Bridge PTS, Incorporated is the only source capable of providing the requested Research and Development services. The North American Industry Classification System (NAICS) code for this requirement is 541380 – Testing Laboratory Services and Veterinary, Natural and Life Sciences. and the small business size standard is $19 million. Any sources that believe they are eligible and capable of providing these services must respond in writing. Responses must be supported with clear and convincing evidence articulating the ability to provide the items outlined above. A request for documentation will not be considered an affirmative response. Information received will be considered solely for the purposes of determining whether a competitive procurement is in the best interest of the Government. If no written responses are received by the date listed below, which reflects fifteen (15) days after the publication of this notice, the contract will be awarded without further remark.
This notice is provided solely as information to the marketplace.
CONTACT INFORMATION: Questions may be submitted to Mr. Eric Zampelli at eric.m.zampelli.civ@health.mil no later than 11:59AM EST on Tuesday, 09 July 2024.
File details come from the government source that posted it. Updated .